GLP-1-based treatment of diabetes does not cause pancreatitis

Credit: CC0 Public Domain

About 50,000 Danish diabetic patients are treated with GLP-1-based medicine. GLP-1 is a hormone that reduces the blood sugar and inhibits the appetite, and it is a frequent treatment for type 2 diabetes and obesity. A known side effect of this particular treatment is that it increases patients’ markers for pancreatitis.

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *